VyGen-Bio

VyGen-Bio is a discovery-stage cellular immunotherapy company focused on the development of transformative technology platforms, including: GEAR-NK, gene editing, natural killer cell-based therapies (NK cells), and optimization for use with targeted antibodies. VyGen-Bio is a wholly-owned subsidiary of Vycellix.